About
Virtue Diagnostics is an in vitro diagnostics (IVD) company established in 2019, specializing in infectious diseases, cancer, and chronic diseases. The company aims to provide comprehensive clinical solutions that cover all disease stages, including early screening, diagnosis, treatment monitoring, and management of minimal residual disease. With a commitment to becoming a leading global diagnostic company, Virtue Diagnostics combines internal development with external collaborations. They utilize advanced technology platforms such as chemiluminescence, clinical mass spectrometry, and molecular diagnostics to support a wide range of diagnostic tools and services. The company operates globally, with R&D in Singapore, manufacturing in Suzhou, China, and a contract research organization in Beijing focused on cancer detection. Their products and services include diagnostic instruments, reagents, and clinical testing services tailored for hospitals, laboratories, and research institutions. Virtue Diagnostics emphasizes expanding its reach in emerging markets like China, Brazil, and Indonesia, aiming to enhance healthcare outcomes through precise and timely diagnostics.
Technologies
Keywords
Company Information
-
Employees 51
-
Founded 2019
-
Annual Revenue $4700000
-
Total Funding $130000000
Location
Central Expy, Singapore, Singapore, Singapore, 55
